Global Information
회사소개 | 문의 | 비교리스트

세계의 바이오매뉴팩처링 시장 : 제품 종류별, 소스별 , 방법별, 기기별, 종류별, 기술별, 용도별, 최종사용자별, 지역별 경쟁, 예측, 기회(2025년)

Global Bio-Manufacturing Market By Product Type, By Source, By Method (Cell Culture, By Equipment, By Type, By Technology, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934742
페이지 정보 영문 114 Pages
가격
US $ 4,450 ₩ 5,101,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,248,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,834,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 바이오매뉴팩처링 시장 : 제품 종류별, 소스별 , 방법별, 기기별, 종류별, 기술별, 용도별, 최종사용자별, 지역별 경쟁, 예측, 기회(2025년) Global Bio-Manufacturing Market By Product Type, By Source, By Method (Cell Culture, By Equipment, By Type, By Technology, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 114 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 바이오매뉴팩처링(Bio-Manufacturing) 시장을 조사했으며, 각 지역 시장 전망, 시장 역학, 주요 동향, 특허 분석, 경쟁 상황 등의 정보를 제공하고, 전략적 제안을 제시하고 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 세계의 바이오매뉴팩처링 시장에 대한 COVID-19의 영향

제4장 주요 요약

제5장 고객의 소리

제6장 세계의 바이오매뉴팩처링 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 종류별(항체(MoAb), 사이토카인, 효소, 융합 단백질, 호르몬, 재조합 단백질, 기타)
    • 소스별(미생물 배양, 식물 기반, 동물 기반)
    • 방법별(세포배양(포유류 vs. 미생물), 혈장 분획, 컬럼 크로마토그래프, 균질화, 기타)
    • 기기별(플라스틱 vs. 강철)
    • 종류별(재이용 가능, 일회용, 자동, 수동)
    • 기술별(다운스트림 처리, 업스트림 처리, 통합, 일회용)
    • 용도별(진단 vs. 치료)
    • 최종사용자별(바이오테크놀러지 및 바이오 제약회사, CMO, CRO, CDMO, 기타)
    • 기업별(2019년)
    • 지역별
  • 제품 시장 맵

제7장 아시아태평양의 바이오매뉴팩처링 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 종류별
    • 소스별
    • 방법별
    • 기기별
    • 종류별
    • 기술별
    • 용도별
    • 최종사용자별
    • 국가별
  • 아시아태평양 : 국가 분석
    • 중국의 바이오매뉴팩처링 시장 전망
    • 인도의 바이오매뉴팩처링 시장 전망
    • 호주의 바이오매뉴팩처링 시장 전망
    • 일본의 바이오매뉴팩처링 시장 전망
    • 한국의 바이오매뉴팩처링 시장 전망

제8장 유럽의 바이오매뉴팩처링 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 종류별
    • 소스별
    • 방법별
    • 기기별
    • 종류별
    • 기술별
    • 용도별
    • 최종사용자별
    • 국가별
  • 유럽 : 국가 분석
    • 프랑스의 바이오매뉴팩처링 시장 전망
    • 독일의 바이오매뉴팩처링 시장 전망
    • 영국의 바이오매뉴팩처링 시장 전망
    • 이탈리아의 바이오매뉴팩처링 시장 전망
    • 스페인의 바이오매뉴팩처링 시장 전망

제9장 북미의 바이오매뉴팩처링 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 종류별
    • 소스별
    • 방법별
    • 기기별
    • 종류별
    • 기술별
    • 용도별
    • 최종사용자별
    • 국가별
  • 북미 : 국가 분석
    • 미국의 바이오매뉴팩처링 시장 전망
    • 멕시코의 바이오매뉴팩처링 시장 전망
    • 캐나다의 바이오매뉴팩처링 시장 전망

제10장 남미의 바이오매뉴팩처링 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 종류별
    • 소스별
    • 방법별
    • 기기별
    • 종류별
    • 기술별
    • 용도별
    • 최종사용자별
    • 국가별
  • 남미 : 국가 분석
    • 브라질의 바이오매뉴팩처링 시장 전망
    • 아르헨티나의 바이오매뉴팩처링 시장 전망
    • 콜롬비아의 바이오매뉴팩처링 시장 전망

제11장 중동과 아프리카의 바이오매뉴팩처링 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품 종류별
    • 소스별
    • 방법별
    • 기기별
    • 종류별
    • 기술별
    • 용도별
    • 최종사용자별
    • 국가별
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국의 바이오매뉴팩처링 시장 전망
    • 사우디아라비아의 바이오매뉴팩처링 시장 전망
    • UAE의 바이오매뉴팩처링 시장 전망
    • 쿠웨이트의 바이오매뉴팩처링 시장 전망

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향

  • 세포주 엔지니어링
  • 일회용 제조 기술
  • 관류 배양
  • 인실리코 모델링
  • 모듈러 팩토리

제14장 특허 분석

제15장 경쟁 상황

  • 경쟁 전망
  • 기업 개요
  • 기업 상세
  • 재무
  • 공급망/밸류체인 분석
  • SWOT 분석
  • 주요 시장 초점과 지역적 입지
  • 계획 투자
  • 시장에서의 포지셔닝
  • 수출입 분석(지역별)
  • 가격 분석(국가별)
  • 주요 기업 개요
    • Abbott Laboratories
    • Abzena Ltd.
    • AGC Biologics GmbH
    • Althea Inc.
    • Amgen Inc.
    • Asymchem Laboratories Inc.
    • Baxter Biopharma Solutions LLC
    • Biocon Ltd.
    • Biogen Inc.
    • Boehringer Ingelheim GmbH
    • Celgene Corporation
    • Danaher Corporation
    • Fujifilm Diosynth Biotechnologies
    • Gilead Sciences, Inc
    • Lonza Group
    • MicroProtein Technologies, Inc.
    • Novo Nordisk
    • Patheon N.V.(Thermo Fischer Scientific)
    • Proteogenix Inc.
    • Proteus Digital Health Inc.

제16장 전략적 제안

KSM 20.06.02

Global bio-manufacturing market is expected to grow at a robust pace over the next five years, driven by the rising prevalence of various chronic diseases such as diabetes, cancer, among others. This has been significantly augmenting the demand for effective and faster treatment of these diseases, which in turn is expected to positively influence the bio-manufacturing market. Additionally, increase in the approvals of biologics is further expected to propel the market during forecast period. Furthermore, increasing expenditure by various governments and major market players and adoption of advanced biomanufacturing strategies to increase the development pipeline of drugs, vaccines, enzymes, among others is expected to foster the market growth through 2025. However, the associated risk of product contamination can hamper the market growth. Also, strict regulatory framework regarding GMP can impede the market growth over next few years.

The global bio-manufacturing market is segmented based on product type, source, method, equipment, type, technology, application, end user, and region. Based on product type, the market can be fragmented into antibodies (MoAb), cytokines, enzymes, fusion proteins, hormones, recombinant proteins and others. The monoclonal antibodies segment is expected to dominate the market over the next five years. Additionally, various monoclonal antibodies such as Humira, Remicade, Enbrel, Rituxan, Avastin and Herceptin are available in the market since 2015 which were manufactured using bio-manufacturing process and are doing very well in the market. Also, various monoclonal antibodies are in BLA or equivalent stages thereby driving the growth of segment. Based on technology, the market can be categorized into downstream processing, upstream processing, integrated and single use. The single use segment is expected to witness significant growth on account of the associated benefits such as reduced risk of contamination, higher flexibility in multiproduct facilities, cost-effectiveness, among others. Based on end user, the market can be segmented into biotechnology & biopharmaceutical companies, CMOs, CROs, CDMOs and others. The CMOs are expected to dominate the market through 2025 due to anticipated increase in demand for clinical and commercial supply of biologics.

Among all the regions, Asia Pacific is expected to witness significant growth in its bio-manufacturing market owing to the increasing healthcare expenditure by the government and various public-private players, especially in countries like China and India. This has allowed a lot of domestic pharmaceutical companies in these countries to develop a range of biologic products such as monoclonal antibodies, recombinant proteins, among others. Additionally, most of the major players operating in the market are expanding in Asia Pacific due to availability of low cost labor as well as manufacturing facilities, thereby creating lucrative opportunities.

Major players operating in the global bio-manufacturing market include Abbott Laboratories, Abzena Ltd., AGC Biologics GmbH, Althea Inc., Amgen Inc., Asymchem Laboratories Inc., Baxter Biopharma Solutions LLC, Biocon Ltd., Biogen Inc., Boehringer Ingelheim GmbH, Celgene Corporation, Danaher Corporation, Fujifilm Diosynth Biotechnologies, Gilead Sciences, Inc, Lonza Group, MicroProtein Technologies, Inc., Novo Nordisk, Patheon N.V. (Thermo Fischer Scientific), Proteogenix Inc., Proteus Digital Health Inc., among others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global bio-manufacturing market from 2015 to 2018.
  • To estimate and forecast the market size of global bio-manufacturing market from 2019 to 2025.
  • To classify and forecast global bio-manufacturing market based on product type, source, method, equipment, type, technology, application, end user, and regional distribution.
  • To identify dominant region or segment in the global bio-manufacturing market.
  • To identify drivers and challenges for global bio-manufacturing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global bio-manufacturing market.
  • To identify and analyze the profile of leading players operating in global bio-manufacturing market.
  • To identify key sustainable strategies adopted by market players in global bio-manufacturing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of market players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global bio-manufacturing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Bio-manufacturing companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to bio-manufacturing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global bio-manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • By Product Type:

Antibodies (MoAb)

Cytokines

Enzymes

Fusion Proteins

Hormones

Recombinant Proteins

Others

  • By Source:

Microbial Culture

Plant-Based

Animal-Based

  • By Method:

Cell Culture

  • Mammalian
  • Microbial

Blood Plasma Fractionation

Column Chromatography

Homogenization

Others

  • By Equipment:

Plastic

Steel

  • By Type:

Reusable

Disposable

Automated

Manual

  • By Technology:

Downstream Processing

Upstream Processing

Integrated

Single Use

  • By Application:

Diagnostics

Therapeutics

  • By End User:

Biotechnology & Biopharmaceutical Companies

CMOs

CROs

CDMOs

Others

  • By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global bio-manufacturing market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Bio-Manufacturing Market

4. Executive Summary

5. Voice of Customer

6. Global Bio-Manufacturing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type (Antibodies (MoAb), Cytokines, Enzymes, Fusion Proteins, Hormones, Recombinant Proteins, Others)
    • 6.2.2. By Source (Microbial Culture, Plant-Based, Animal-Based)
    • 6.2.3. By Method (Cell Culture (Mammalian v/s Microbial), Blood Plasma Fractionation, Column Chromatography, Homogenization, Others)
    • 6.2.4. By Equipment (Plastic v/s Steel)
    • 6.2.5. By Type (Reusable, Disposable, Automated, Manual)
    • 6.2.6. By Technology (Downstream Processing, Upstream Processing, Integrated, Single Use)
    • 6.2.7. By Application (Diagnostics v/s Therapeutics)
    • 6.2.8. By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others)
    • 6.2.9. By Company (2019)
    • 6.2.10. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Bio-Manufacturing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Source
    • 7.2.3. By Method
    • 7.2.4. By Equipment
    • 7.2.5. By Type
    • 7.2.6. By Technology
    • 7.2.7. By Application
    • 7.2.8. By End User
    • 7.2.9. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Bio-Manufacturing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Source
        • 7.3.1.2.3. By Method
        • 7.3.1.2.4. By Equipment
        • 7.3.1.2.5. By Type
        • 7.3.1.2.6. By Technology
        • 7.3.1.2.7. By Application
        • 7.3.1.2.8. By End User
    • 7.3.2. India Bio-Manufacturing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Source
        • 7.3.2.2.3. By Method
        • 7.3.2.2.4. By Equipment
        • 7.3.2.2.5. By Type
        • 7.3.2.2.6. By Technology
        • 7.3.2.2.7. By Application
        • 7.3.2.2.8. By End User
    • 7.3.3. Australia Bio-Manufacturing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Source
        • 7.3.3.2.3. By Method
        • 7.3.3.2.4. By Equipment
        • 7.3.3.2.5. By Type
        • 7.3.3.2.6. By Technology
        • 7.3.3.2.7. By Application
        • 7.3.3.2.8. By End User
    • 7.3.4. Japan Bio-Manufacturing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Source
        • 7.3.4.2.3. By Method
        • 7.3.4.2.4. By Equipment
        • 7.3.4.2.5. By Type
        • 7.3.4.2.6. By Technology
        • 7.3.4.2.7. By Application
        • 7.3.4.2.8. By End User
    • 7.3.5. South Korea Bio-Manufacturing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Source
        • 7.3.5.2.3. By Method
        • 7.3.5.2.4. By Equipment
        • 7.3.5.2.5. By Type
        • 7.3.5.2.6. By Technology
        • 7.3.5.2.7. By Application
        • 7.3.5.2.8. By End User

8. Europe Bio-Manufacturing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Source
    • 8.2.3. By Method
    • 8.2.4. By Equipment
    • 8.2.5. By Type
    • 8.2.6. By Technology
    • 8.2.7. By Application
    • 8.2.8. By End User
    • 8.2.9. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Bio-Manufacturing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Source
        • 8.3.1.2.3. By Method
        • 8.3.1.2.4. By Equipment
        • 8.3.1.2.5. By Type
        • 8.3.1.2.6. By Technology
        • 8.3.1.2.7. By Application
        • 8.3.1.2.8. By End User
    • 8.3.2. Germany Bio-Manufacturing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Source
        • 8.3.2.2.3. By Method
        • 8.3.2.2.4. By Equipment
        • 8.3.2.2.5. By Type
        • 8.3.2.2.6. By Technology
        • 8.3.2.2.7. By Application
        • 8.3.2.2.8. By End User
    • 8.3.3. United Kingdom Bio-Manufacturing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Source
        • 8.3.3.2.3. By Method
        • 8.3.3.2.4. By Equipment
        • 8.3.3.2.5. By Type
        • 8.3.3.2.6. By Technology
        • 8.3.3.2.7. By Application
        • 8.3.3.2.8. By End User
    • 8.3.4. Italy Bio-Manufacturing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Source
        • 8.3.4.2.3. By Method
        • 8.3.4.2.4. By Equipment
        • 8.3.4.2.5. By Type
        • 8.3.4.2.6. By Technology
        • 8.3.4.2.7. By Application
        • 8.3.4.2.8. By End User
    • 8.3.5. Spain Bio-Manufacturing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Source
        • 8.3.5.2.3. By Method
        • 8.3.5.2.4. By Equipment
        • 8.3.5.2.5. By Type
        • 8.3.5.2.6. By Technology
        • 8.3.5.2.7. By Application
        • 8.3.5.2.8. By End User

9. North America Bio-Manufacturing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Source
    • 9.2.3. By Method
    • 9.2.4. By Equipment
    • 9.2.5. By Type
    • 9.2.6. By Technology
    • 9.2.7. By Application
    • 9.2.8. By End User
    • 9.2.9. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Bio-Manufacturing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Source
        • 9.3.1.2.3. By Method
        • 9.3.1.2.4. By Equipment
        • 9.3.1.2.5. By Type
        • 9.3.1.2.6. By Technology
        • 9.3.1.2.7. By Application
        • 9.3.1.2.8. By End User
    • 9.3.2. Mexico Bio-Manufacturing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Source
        • 9.3.2.2.3. By Method
        • 9.3.2.2.4. By Equipment
        • 9.3.2.2.5. By Type
        • 9.3.2.2.6. By Technology
        • 9.3.2.2.7. By Application
        • 9.3.2.2.8. By End User
    • 9.3.3. Canada Bio-Manufacturing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Source
        • 9.3.3.2.3. By Method
        • 9.3.3.2.4. By Equipment
        • 9.3.3.2.5. By Type
        • 9.3.3.2.6. By Technology
        • 9.3.3.2.7. By Application
        • 9.3.3.2.8. By End User

10. South America Bio-Manufacturing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Source
    • 10.2.3. By Method
    • 10.2.4. By Equipment
    • 10.2.5. By Type
    • 10.2.6. By Technology
    • 10.2.7. By Application
    • 10.2.8. By End User
    • 10.2.9. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Bio-Manufacturing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Source
        • 10.3.1.2.3. By Method
        • 10.3.1.2.4. By Equipment
        • 10.3.1.2.5. By Type
        • 10.3.1.2.6. By Technology
        • 10.3.1.2.7. By Application
        • 10.3.1.2.8. By End User
    • 10.3.2. Argentina Bio-Manufacturing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Source
        • 10.3.2.2.3. By Method
        • 10.3.2.2.4. By Equipment
        • 10.3.2.2.5. By Type
        • 10.3.2.2.6. By Technology
        • 10.3.2.2.7. By Application
        • 10.3.2.2.8. By End User
    • 10.3.3. Colombia Bio-Manufacturing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Source
        • 10.3.3.2.3. By Method
        • 10.3.3.2.4. By Equipment
        • 10.3.3.2.5. By Type
        • 10.3.3.2.6. By Technology
        • 10.3.3.2.7. By Application
        • 10.3.3.2.8. By End User

11. Middle East and Africa Bio-Manufacturing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Source
    • 11.2.3. By Method
    • 11.2.4. By Equipment
    • 11.2.5. By Type
    • 11.2.6. By Technology
    • 11.2.7. By Application
    • 11.2.8. By End User
    • 11.2.9. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Bio-Manufacturing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product Type
        • 11.3.1.2.2. By Source
        • 11.3.1.2.3. By Method
        • 11.3.1.2.4. By Equipment
        • 11.3.1.2.5. By Type
        • 11.3.1.2.6. By Technology
        • 11.3.1.2.7. By Application
        • 11.3.1.2.8. By End User
    • 11.3.2. Saudi Arabia Bio-Manufacturing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product Type
        • 11.3.2.2.2. By Source
        • 11.3.2.2.3. By Method
        • 11.3.2.2.4. By Equipment
        • 11.3.2.2.5. By Type
        • 11.3.2.2.6. By Technology
        • 11.3.2.2.7. By Application
        • 11.3.2.2.8. By End User
    • 11.3.3. UAE Bio-Manufacturing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product Type
        • 11.3.3.2.2. By Source
        • 11.3.3.2.3. By Method
        • 11.3.3.2.4. By Equipment
        • 11.3.3.2.5. By Type
        • 11.3.3.2.6. By Technology
        • 11.3.3.2.7. By Application
        • 11.3.3.2.8. By End User
    • 11.3.4. Kuwait Bio-Manufacturing Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product Type
        • 11.3.4.2.2. By Source
        • 11.3.4.2.3. By Method
        • 11.3.4.2.4. By Equipment
        • 11.3.4.2.5. By Type
        • 11.3.4.2.6. By Technology
        • 11.3.4.2.7. By Application
        • 11.3.4.2.8. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Cell Line Engineering
  • 13.2. Disposable Manufacturing Technology
  • 13.3. Perfusion Culture
  • 13.4. In-Silico Modelling
  • 13.5. Modular Factories

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Competition Outlook
  • 15.2. Company Profiles
  • 15.3. Company Details
  • 15.4. Financials (As Reported)
  • 15.5. Supply/ Value Chain Analysis
  • 15.6. SWOT Analysis
  • 15.7. Key Market Focus and Geographical Presence
  • 15.8. Planned Investments
  • 15.9. Market Positioning
  • 15.10. Import Export Analysis (By Region)
  • 15.11. Pricing Analysis (By Country)
  • 15.12. Leading Players Profiled
    • 15.12.1. Abbott Laboratories
    • 15.12.2. Abzena Ltd.
    • 15.12.3. AGC Biologics GmbH
    • 15.12.4. Althea Inc.
    • 15.12.5. Amgen Inc.
    • 15.12.6. Asymchem Laboratories Inc.
    • 15.12.7. Baxter Biopharma Solutions LLC
    • 15.12.8. Biocon Ltd.
    • 15.12.9. Biogen Inc.
    • 15.12.10. Boehringer Ingelheim GmbH
    • 15.12.11. Celgene Corporation
    • 15.12.12. Danaher Corporation
    • 15.12.13. Fujifilm Diosynth Biotechnologies
    • 15.12.14. Gilead Sciences, Inc
    • 15.12.15. Lonza Group
    • 15.12.16. MicroProtein Technologies, Inc.
    • 15.12.17. Novo Nordisk
    • 15.12.18. Patheon N.V. (Thermo Fischer Scientific)
    • 15.12.19. Proteogenix Inc.
    • 15.12.20. Proteus Digital Health Inc.

16. Strategic Recommendations

Back to Top
전화 문의
F A Q